In patient-years, this incidence corresponds to 2.73 per 1000 patient-years exposed (considering first exposure to an TNF inhibitor agent), while the cumulative incidence of TB in the overall study population was 2.86 per 1000 patient-years. Here, TNF is linked to tuberculosis.